US markets can keep rallying, but the margin for error is shrinking

As investors look toward 2026, two of Wall Street’s most influential strategy teams agree on the destination but differ on the path. 

Citi sees the US equity market extending its bull run, albeit with greater volatility and less margin for error. UBS, by contrast, argues that the market is undergoing a more selective phase of the cycle, in which speculative growth is slipping down the rankings and capital is rotating toward earnings-backed, policy-supported areas.

Read together, the message is clear. The bull market is not over, but it is evolving.

Index upside increasingly depends on fundamentals broadening beyond mega cap growth, while stock selection matters more than it has in years.

Citi’s base case: upside remains, but the hurdle is high

Citi’s 2026 outlook is unambiguously constructive. The bank sets a base-case target of 7700 for the S&P 500, driven by aggressive earnings assumptions of $320 in index earnings.

“We see further upside for US equities during 2026 reflecting a broadening fundamental setup,” Citi writes, while cautioning that “a high valuation starting point increases downside risk relative to upside potential”.

Citi’s bull case sits at 8300, while its bear case drops sharply to 5700, reflecting how little room there is for disappointment when valuations are already elevated.

Importantly, Citi does not see valuation as an immediate constraint, provided earnings deliver. The team expects a modest compression in multiples from 25x to 24x, offset by earnings growth and a supportive Fed backdrop.

Broadening beyond mega-cap growth is the key theme

The core of Citi’s argument is not simply higher earnings, but who delivers them. While mega-cap growth stocks remain central, Citi expects leadership to broaden meaningfully across sectors and down the market cap spectrum.

“We anticipate an incremental shift from AI enablers to AI adopters or users in 2026,” Citi notes, arguing that productivity gains should increasingly show up across corporate America rather than remaining concentrated in hyperscalers.

Citi also highlights US small and mid-caps as a relative opportunity. Valuations are closer to historical averages, and earnings revisions have stabilised, setting up a potential convergence trade if growth improves.

“The broadening playbook we envisage includes a differentiated set-up down cap,” the team writes.

UBS: themes are rotating, not disappearing

UBS approaches the market from a different angle. Rather than starting with index targets, it uses its REVS framework, which evaluates regime, earnings, valuations and sentiment across thematic baskets.

The conclusion is striking. Speculative growth themes are losing momentum, while investment-driven and policy-supported areas are climbing the rankings.

“Speculative Growth has fallen further down our scorecard as risks continue to mount,” UBS writes. 

“Valuations remain very stretched, and any stall in earnings momentum could quickly bring the valuation overhang into focus”.

At the same time, UBS continues to favour AI, but in a more nuanced way.

“AI themes remain a BUY, though they rank lower on our scorecard,” the team notes, highlighting AI power and renewable infrastructure rather than software-led speculation.

Where Citi and UBS agree

Despite their different frameworks, the overlap is meaningful.

Both agree that:

• Earnings delivery matters more than multiple expansion.
• Leadership must broaden beyond the Magnificent Seven.
• Productivity and capital investment are the dominant macro forces.
• Volatility is not a bug, but a feature of the next phase of the bull market.

Citi explicitly warns that “ongoing bouts of volatility should be expected and may be more acute given implicit growth expectations”. UBS reaches a similar conclusion based on its sentiment and crowding metrics, which indicate elevated risk in crowded growth trades.

In short, both see opportunity, but not through passive exposure alone.

Where they diverge

The divergence lies in what investors should own.

Citi remains comfortable with the index moving higher, provided earnings hold up. It continues to see upside in growth, especially where companies can sustain beat-and-raise dynamics.

UBS is more sceptical of crowded, valuation-stretched growth exposure. Its models push investors toward sectors with tangible earnings momentum, policy tailwinds and reasonable valuations.

In the US, UBS’s top-scoring sectors are Utilities, Communication Services and Healthcare, while Real Estate ranks at the bottom.

This contrast highlights an important nuance. Citi’s bullishness is conditional. UBS’s positioning is selective.

Specific investment opportunities highlighted

UBS goes further in naming specific beneficiaries within favoured themes.

In Healthcare and GLP-1 exposure, UBS highlights Eli Lilly (NYSE: LLY), Amgen (NASDAQ: AMGN) and Cardinal Health (NYSE: CAH), citing improving earnings momentum and sentiment.

In US Infrastructure and Reshoring, top-ranked names include Caterpillar (NYSE: CAT), Commercial Metals Company (NYSE: CMC) and Primoris Services (NYSE: PRIM), reflecting confidence in sustained capital expenditure driven by policy incentives and productivity investment. 

Citi is less prescriptive at the stock level in this note, but its sector earnings forecasts point toward Financials, Industrials, Health Care and Materials as areas where consensus may still be too low.

What it means for investors

Taken together, these notes argue for a shift in mindset.

This is no longer a market where valuation can be ignored or where index exposure alone does the work. The next leg of the bull market demands discipline, selectivity and an acceptance of volatility.

Citi believes the bull market can persist, but only if earnings do the heavy lifting. UBS shows where that earnings support is most credible today.

For investors, the implication is clear. The easy money phase is behind us. The opportunity now lies in backing real growth, real investment and real productivity.